These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38473212)

  • 1. Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.
    Dal Buono A; Puccini A; Franchellucci G; Airoldi M; Bartolini M; Bianchi P; Santoro A; Repici A; Hassan C
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies.
    Sei S; Ahadova A; Keskin DB; Bohaumilitzky L; Gebert J; von Knebel Doeberitz M; Lipkin SM; Kloor M
    Front Oncol; 2023; 13():1147590. PubMed ID: 37035178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current clinical topics of Lynch syndrome.
    Tanakaya K
    Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is HLA type a possible cancer risk modifier in Lynch syndrome?
    Ahadova A; Witt J; Haupt S; Gallon R; Hüneburg R; Nattermann J; Ten Broeke S; Bohaumilitzky L; Hernandez-Sanchez A; Santibanez-Koref M; Jackson MS; Ahtiainen M; Pylvänäinen K; Andini K; Grolmusz VK; Möslein G; Dominguez-Valentin M; Møller P; Fürst D; Sijmons R; Borthwick GM; Burn J; Mecklin JP; Heuveline V; von Knebel Doeberitz M; Seppälä T; Kloor M
    Int J Cancer; 2023 May; 152(10):2024-2031. PubMed ID: 36214792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mismatch repair testing in evaluation of Lynch syndrome: The gap between preferred and current practices.
    Williams D; Vilar E; Shakrukh Hashmi S; Choates M; Noblin S; Mork M
    J Genet Couns; 2020 Oct; 29(5):728-736. PubMed ID: 31896172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
    Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
    PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
    Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
    J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.
    Rossi BM; Palmero EI; López-Kostner F; Sarroca C; Vaccaro CA; Spirandelli F; Ashton-Prolla P; Rodriguez Y; de Campos Reis Galvão H; Reis RM; Escremim de Paula A; Capochin Romagnolo LG; Alvarez K; Della Valle A; Neffa F; Kalfayan PG; Spirandelli E; Chialina S; Gutiérrez Angulo M; Castro-Mujica MDC; Sanchez de Monte J; Quispe R; da Silva SD; Rossi NT; Barletta-Carrillo C; Revollo S; Taborga X; Morillas LL; Tubeuf H; Monteiro-Santos EM; Piñero TA; Dominguez-Barrera C; Wernhoff P; Martins A; Hovig E; Møller P; Dominguez-Valentin M
    BMC Cancer; 2017 Sep; 17(1):623. PubMed ID: 28874130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learnt from the implementation of a colorectal cancer screening programme for lynch syndrome in a tertiary public hospital.
    Dueñas N; Navarro M; Sanjuán X; Ruiz N; Iglesias S; Matias-Guiu X; Guardiola J; Kreisler E; Biondo S; González S; Legido R; Blanco A; Navarro S; Asiain L; Santos C; Capellá G; Pineda M; Brunet J
    Cancer Epidemiol; 2023 Feb; 82():102291. PubMed ID: 36410089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics, diagnosis and treatment of Lynch syndrome: Old lessons and current challenges.
    Duraturo F; Liccardo R; De Rosa M; Izzo P
    Oncol Lett; 2019 Mar; 17(3):3048-3054. PubMed ID: 30867733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
    Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A
    World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
    Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
    BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Lynch syndrome identification in selected and unselected gynecological cancers.
    Carnevali I; Sahnane N; Chiaravalli AM; Di Lauro E; Facco C; Facchi S; Casarin J; Ghezzi F; Sessa F; Tibiletti MG
    Eur J Cancer Prev; 2022 Jul; 31(4):369-376. PubMed ID: 34519692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
    Chang K; Taggart MW; Reyes-Uribe L; Borras E; Riquelme E; Barnett RM; Leoni G; San Lucas FA; Catanese MT; Mori F; Diodoro MG; You YN; Hawk ET; Roszik J; Scheet P; Kopetz S; Nicosia A; Scarselli E; Lynch PM; McAllister F; Vilar E
    JAMA Oncol; 2018 Aug; 4(8):1085-1092. PubMed ID: 29710228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
    Latham A; Srinivasan P; Kemel Y; Shia J; Bandlamudi C; Mandelker D; Middha S; Hechtman J; Zehir A; Dubard-Gault M; Tran C; Stewart C; Sheehan M; Penson A; DeLair D; Yaeger R; Vijai J; Mukherjee S; Galle J; Dickson MA; Janjigian Y; O'Reilly EM; Segal N; Saltz LB; Reidy-Lagunes D; Varghese AM; Bajorin D; Carlo MI; Cadoo K; Walsh MF; Weiser M; Aguilar JG; Klimstra DS; Diaz LA; Baselga J; Zhang L; Ladanyi M; Hyman DM; Solit DB; Robson ME; Taylor BS; Offit K; Berger MF; Stadler ZK
    J Clin Oncol; 2019 Feb; 37(4):286-295. PubMed ID: 30376427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch Syndrome Genetics and Clinical Implications.
    Peltomäki P; Nyström M; Mecklin JP; Seppälä TT
    Gastroenterology; 2023 Apr; 164(5):783-799. PubMed ID: 36706841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.